z-logo
open-access-imgOpen Access
Epigenetic therapy with chidamide alone or combined with 5‑azacitidine exerts antitumour effects on acute myeloid leukaemia cells in vitro
Author(s) -
Zheng Li,
Jian Zhang,
Min Zhou,
Jinli Li,
QiaoCheng Qiu,
Jianhong Fu,
Shengli Xue,
Huiying Qiu
Publication year - 2022
Publication title -
oncology reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.094
H-Index - 96
eISSN - 1791-2431
pISSN - 1021-335X
DOI - 10.3892/or.2022.8277
Subject(s) - azacitidine , in vitro , cancer research , epigenetics , cell cycle , molecular medicine , oncogene , biology , myeloid leukaemia , myeloid , cancer , pharmacology , medicine , dna methylation , genetics , gene , gene expression

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom